(Q54376679)

29 May 2018

http://europepmc.org/abstract/MED/9446596

title

Recombinant human single chain Fv antibodies recognizing human interleukin-6. Specific targeting of cytokine-secreting cells. (English)

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

1 reference

4

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

author name string

Krebs B

series ordinal

1

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

Griffin H

series ordinal

2

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

Winter G

series ordinal

3

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

language of work or name

English

0 references

publication date

1 January 1998

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Journal of Biological Chemistry

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

volume

273

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

issue

5

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

page(s)

2858-2865

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

cites work

Hematopoietic receptor complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Interleukin-6 in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

The therapeutic potential of interleukin-6 hyperagonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Making antibodies by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

"Diabodies": small bivalent and bispecific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Making antibody fragments using phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Production of hybridoma growth factor by human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: a contribution to the self-limitation of cellular immune reactions in reactive arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

The three carboxy-terminal amino acids of human interleukin-6 are essential for its biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

By-passing immunization: building high affinity human antibodies by chain shuffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Fate of interleukin-6 in the rat. Involvement of skin in its catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Identification of Single Amino Acid Residues of Human IL-6 Involved in Receptor Binding and Signal Initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

A bioactive designer cytokine for human hematopoietic progenitor cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.5.2858

21 January 2018

Identifiers

DOI

10.1074/JBC.273.5.2858

1 reference

29 May 2018

http://europepmc.org/abstract/MED/9446596

1 reference

29 May 2018